How to appeal a Blue Cross NC interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Blue Cross NC-specific note: BCBS licensee for North Carolina (~4.3M members). Prime Therapeutics PBM. NC DOI oversight. Blue Premier is the high-profile value-based care program. Recently divested some Medicaid business; Healthy Blue (joint venture with Elevance) handles NC Medicaid.

What Blue Cross NC's policy requires for interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty

Cited policy: Anthem clinical guideline Vertebroplasty and Kyphoplasty (BCBS plans similar)

Acute (<6-12 wk) painful VCF on MRI STIR/T2 edema confirmation; refractory to >=4-6 wk conservative therapy (analgesics, brace, PT); pain NRS >=5; underlying osteoporosis or pathologic fracture; absence of retropulsion / cord compression / unstable fracture; absence of contraindication.

How Blue Cross NC denies interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty — and how to counter it

Where Blue Cross NC pushes back: 1) Fracture not documented as acute (no STIR/T2); 2) Conservative therapy duration insufficient; 3) Citing INVEST / Buchbinder / Kallmes negative trials as evidence of futility; 4) Multilevel cement augmentation 'excessive'.

Counter-arguments that hold up: Cite VAPOUR (Clark Lancet 2016) — vertebroplasty positive for severe acute VCF; VERTOS IV (Firanescu BMJ 2018) — positive vs sham; AANS/CNS/SIR/ASNR/ASSR Practice Parameter on Vertebral Augmentation; NASS Coverage Policy. Submit MRI with STIR/T2 edema confirming acuity. Distinguish VAPOUR / VERTOS IV inclusion criteria (acute, severe pain, edema-positive) from older negative trials (chronic / asymptomatic / mixed).

What Blue Cross NC typically denies for interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty

Across Blue Cross NC's commercial and Medicare books, denials cluster around a small number of patterns. For interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty, expect:

• Step therapy via Prime Therapeutics
• Blue Premier value-based arrangement disputes
• Out-of-network reductions
• Specialty drug PA

Treatments most often denied in this category

These are the interventional radiology — ufe, pae, tips, y-90, tumor ablation, kyphoplasty treatments most often flagged for prior auth, step therapy, or medical necessity review:

• UFE (uterine fibroid embolization)
• PAE (prostate artery embolization)
• TIPS
• Y-90 radioembolization
• TACE (HCC)
• Cryoablation

How to submit the appeal to Blue Cross NC

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Blue Cross NC cited in the denial.
3. File the appeal through Blue Cross NC's portal (members: https://www.bluecrossnc.com ; providers: https://www.bluecrossnc.com/providers). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In NC, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Blue Cross NC's prior-authorization criteria by drug: Blue Cross NC PA criteria on ApprovalHelp.